Global Artificial Lung Market Research Report 2022

An artificial lung (AL) is a prosthetic device that provides oxygenation of blood and removal of carbon dioxide from the blood. The AL is intended to take over some of the functionality of biological lungs.
Due to the COVID-19 pandemic, the global Artificial Lung market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Artificial Lung market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Artificial Lung landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Bubble Artificial Lung accounting for % of the Artificial Lung global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Artificial Lung include ALung Technologies, Breethe, Haemair, Lung Biotechnology PBC, McGowan Institute for Regenerative Medicine, MedArray, Michigan Critical Care Consultants, Miromatrix Medical and The Charles Stark Draper Laboratory and etc. In terms of revenue, the global 3 largest players have a % market share of Artificial Lung in 2021.
This report focuses on Artificial Lung volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Artificial Lung market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Artificial Lung Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Bubble Artificial Lung
Membrane Artificial Lung
Segment by Application
Hospital
Emergency Center
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
ALung Technologies
Breethe
Haemair
Lung Biotechnology PBC
McGowan Institute for Regenerative Medicine
MedArray
Michigan Critical Care Consultants
Miromatrix Medical
The Charles Stark Draper Laboratory
Xenios